The past year has been hectic. The global COVID-19 pandemic arrived, a worldwide recession followed; US-China turmoil continued, while geopolitical and geo-economic tensions are rising across the world. And all these matters seem interrelated. So, how is Indonesia doing amid these developments? And, how do they exactly impact on Indonesia's economy and society? It is time to sit down with Indonesia Investments' Managing Director Richard van der Schaar to hear his thoughts on these matters.
Update COVID-19 in Indonesia: 365,240 confirmed infections, 12,617 deaths (19 October 2020)
19 October 2020 (closed)
USD/IDR (14,697) +39.01 +0.27%
EUR/IDR (17,406) +48.41 +0.28%
Jakarta Composite Index (5,126.33) +22.92 +0.45%
Indonesia Investments' News Columns section contains articles with a detailed analysis regarding topics that have high news value in Indonesia and can be regarded as topics that are capable of influencing Indonesia's investment climate. Most columns published in this section cover subjects related to politics, economics and social matters. By following these publications on a regular basis, one will be apprised of what is happening in Indonesia and - just as important - understand why it is happening.
Across the world, concern over the COVID-19 pandemic grew in September 2020 as the number of new COVID-19 cases continued to rise rapidly. Worldwide, at the end of September 2020, some 34 million people have been infected with the virus, while more than one million people have died after contracting the virus.
On 05 August 2020, Statistics Indonesia (BPS) released Indonesia’s gross domestic product (GDP) data for the second quarter of 2020. These data, which were highly anticipated among analysts and policymakers, are crucial to comprehend how – and to what extend – the self-imposed social and business restrictions (made in response to the COVID-19 pandemic) have impacted on the Indonesian economy.
Across the globe governments and pharmaceutical companies are busy working on a vaccine to make people immune against the novel coronavirus (COVID-19). Having the availability of a reliable vaccine would be a solution because COVID-19 seems to spread quite easily, while the majority of the world's population remains vulnerable to the virus.